Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001144204-17-010134
Filing Date
2017-02-21
Accepted
2017-02-21 16:01:47
Documents
3
Group Members
DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G v460065_sc13g.htm SC 13G 45580
2 EXHIBIT 1 v460065_ex1.htm EX-99.1 5790
3 EXHIBIT 2 v460065_ex2.htm EX-99.2 4304
  Complete submission text file 0001144204-17-010134.txt   57296
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-48577 | Film No.: 17625020
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

EIN.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G